Nomura Holdings Inc Spring Works Therapeutics, Inc. Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $240,348 - $472,575	12,690 New	12,690 $463,000
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $3.04 Million - $4.15 Million	-121,816 Reduced 63.33%	70,521 $1.82 Million
Q4 2022 Feb 15, 2023	BUY	$21.73 - $28.72 $4.18 Million - $5.52 Million	192,337 New	192,337 $5 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $9.3 Million - $30.4 Million	506,772 New	506,772 $13.4 Million

237

68.9M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.25B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.